Stay updated on Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone
Sign up to get notified when there's something new on the Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone page.

Latest updates to the Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe recruitment status is updated to 'No longer looking for participants' and the record's revision advances to v3.6.0, replacing the previous v3.5.5 tag.SummaryDifference0.4%

- Check19 days agoChange DetectedA new revision entry v3.5.5 was added to the history, and the previous revision v3.5.4 was removed.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded results-related sections (Results Posted, Adverse Events, Outcome Measures (Results), and Outcome Measures) along with an updated Study Status, indicating that study results are now available and being tracked in the record. The history also reflects the removal of the earlier 'Results Submitted' entry.SummaryDifference0.7%

- Check40 days agoChange DetectedThe page history now shows a newer revision label (v3.5.4) replacing the previous one (v3.5.3). This indicates an update to the page version in the study history timeline.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision label changes from v3.5.2 to v3.5.3, reflecting an interface/version update rather than a substantive change to the trial’s recorded information.SummaryDifference0.1%

- Check68 days agoChange DetectedThe revision adds core study-data sections to the history (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Design, Oversight) and introduces a QC status ('Has Not Concluded').SummaryDifference2%

Stay in the know with updates to Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone page.